• Go to the menu
  • Go to content
Bioregate Logo RFI
Rechercher
My accountLogin
  • fr
  • en
Contact Donate
Menu
  • Bioregate
    • Missions
    • Consortium
    • Organization
    • Operational team
    • Regional skills overview
  • Skills
    • Players Network
      • Research laboratories
      • Technology platforms
      • Clinical Innovation
      • Companies
    • Innovation supports
  • Projects
    • Research projects
    • Clinical trials
    • R&D projects
    • Publications
  • Education & Training
  • Partnerships
  • Agenda & News
  • Calls for projects
  • Bioregate Forum
    • 2016 Edition
    • 2018 Edition
  1. Home
  2. 2018

6 February 2018

Safety and Long-Term Efficacy of AAV4 Gene Therapy in Patients with RPE65 Leber Congenital Amaurosis

The aim of this study was the evaluation of the safety and efficacy of unilateral

Regenerative Medicine
Research
Read more

20 November 2017

BOGUS

In both directing and fostering the natural ability of stem cells to self-organize, significant advances

Regenerative Medicine
Tools for Restorative and Regenerative Medicine
Research
Read more

8 November 2017

REVIVEME

During acute myocardial infarct (AMI), a multidisciplinary approach is often needed. Our team has evaluated the therapeutic potential of bioengineered nanoscaled extracellular vesicles (EVs) released from plasma membrane.

Regenerative Medicine
Tools for Restorative and Regenerative Medicine
Research
Read more

Previous page 1 2 3
Back to top
  • Logo RFI
  • Bioregate
  • Contact
  • Terms and conditions
  • Site map

Led by

  • Université - Nantes

Funded by

In partnership with

  • logo-lemans-universite
  • Atlanpole-Biotherapies
© 2026 Bioregate All rights reserved.